Gelteq Limited UNDERWRITING AGREEMENTUnderwriting Agreement • February 29th, 2024 • Gelteq LTD • Pharmaceutical preparations • New York
Executive Service AgreementGelteq LTD • March 17th, 2023 • Pharmaceutical preparations
ContractGelteq LTD • February 6th, 2023 • Pharmaceutical preparations
Pursuant to Item 601(b)(10)(iv) of Regulation S-K, certain identified information marked with [*****] has been excluded from the exhibit because it is both (i) not material and (ii) the type that the registrant treats as private or confidential.
ContractShare Sale Agreement • February 6th, 2023 • Gelteq LTD • Pharmaceutical preparations
Pursuant to Item 601(b)(10)(iv) of Regulation S-K, certain identified information marked with [*****] has been excluded from the exhibit because it is both (i) not material and (ii) would be competitively harmful if publicly disclosed
ContractShare Sale Agreement • February 6th, 2023 • Gelteq LTD • Pharmaceutical preparations
Pursuant to Item 601(b)(10)(iv) of Regulation S-K, certain identified information marked with [*****] has been excluded from the exhibit because it is both (i) not material and (ii) would be competitively harmful if publicly disclosed
Gelteq Limited UNDERWRITING AGREEMENTUnderwriting Agreement • March 17th, 2023 • Gelteq LTD • Pharmaceutical preparations • Delaware
CONSULTING AGREEMENTConsulting Agreement • August 30th, 2022 • Gelteq LTD • Pharmaceutical preparations • New York
WHEREAS the Company has requested the Contractor to perform certain Services as hereinafter set forth and the Contractor has agreed to perform such Services on and subject to the terms and conditions hereinafter contained;
CONSULTING AGREEMENTConsulting Agreement • August 30th, 2022 • Gelteq LTD • Pharmaceutical preparations • New York
THIS CONSULTING AGREEMENT (“Agreement”) is entered into on the 24 March 2022 by and between Ocean Street Partners, Inc. (hereinafter “Consultant”) and GelTeq Pty Ltd, an Australian corporation (hereinafter “Company”).
CONSULTING AGREEMENTConsulting Agreement • February 29th, 2024 • Gelteq LTD • Pharmaceutical preparations • New York
THIS CONSULTING AGREEMENT (“Agreement”) is entered into on the 15th day of October 2023 by and between Ocean Street Partners, Inc. (hereinafter “Consultant”) and Gelteq Ltd, an Australian corporation (hereinafter “Company”).
Gelteq Authorised Licensee Agreement – Pilot ProgramLicensee Agreement • August 30th, 2022 • Gelteq LTD • Pharmaceutical preparations
ContractLoan Agreement • August 30th, 2022 • Gelteq LTD • Pharmaceutical preparations
Pursuant to Item 601(b)(10)(iv) of Regulation S-K, certain identified information marked with [*****] has been excluded from the exhibit because it is both (i) not material and (ii) would be competitively harmful if publicly disclosed
WASATCH FORMULATION DEVELOPMENT AGREEMENTWasatch Formulation Development Agreement • August 30th, 2022 • Gelteq LTD • Pharmaceutical preparations • Utah
This Formulation Development Agreement (“Agreement”) is entered into by and between Wasatch Product Development LLC, a Developer organized under the laws of Utah, having its principal place of business at 427 West 11950 South, Draper, Utah 84020 (“Developer”) and Gelteq Pty Ltd a Developer organized under the laws of Victoria, Australia, having its principal place of business at 641 Glenhuntly Rd, Caulfield Victoria 3162 (“Client”) as of the 1st day of February , 2022 (“Effective Date”).
ContractMaster Research Services Agreement • June 30th, 2022 • Gelteq LTD • Pharmaceutical preparations • Victoria
Pursuant to Item 601(b)(10)(iv) of Regulation S-K, certain identified information marked with [*****] has been excluded from the exhibit because it is both (i) not material and (ii) would be competitively harmful if publicly disclosed.
Parties Adjutor Healthcare Pty Ltd Gelteq Pty Ltd Master Services AgreementMaster Services Agreement • August 30th, 2022 • Gelteq LTD • Pharmaceutical preparations • Victoria
MASTER RESEARCH SERVICES AGREEMENTServices Agreement • August 30th, 2022 • Gelteq LTD • Pharmaceutical preparations • Victoria
ContractGelteq LTD • June 30th, 2022 • Pharmaceutical preparations
Pursuant to Item 601(b)(10)(iv) of Regulation S-K, certain identified information marked with [*****] has been excluded from the exhibit because it is both (i) not material and (ii) would be competitively harmful if publicly disclosed.
Variation AgreementGelteq LTD • August 30th, 2022 • Pharmaceutical preparations
ContractLoan Agreement • December 5th, 2023 • Gelteq LTD • Pharmaceutical preparations
Pursuant to Item 601(b)(10)(iv) of Regulation S-K, certain identified information marked with [*****] has been excluded from the exhibit because it is both (i) not material and (ii) the type that the registrant treats as private or confidential
AGREEMENT FOR THE PROVISION OF OFFICE SPACEGelteq LTD • August 30th, 2022 • Pharmaceutical preparations • Victoria
ContractLoan Agreement • February 29th, 2024 • Gelteq LTD • Pharmaceutical preparations
Pursuant to Item 601(b)(10)(iv) of Regulation S-K, certain identified information marked with [*****] has been excluded from the exhibit because it is both (i) not material and (ii) the type that the registrant treats as private or confidential
ContractGelteq LTD • June 30th, 2022 • Pharmaceutical preparations • Victoria
Pursuant to Item 601(b)(10)(iv) of Regulation S-K, certain identified information marked with [*****] has been excluded from the exhibit because it is both (i) not material and (ii) would be competitively harmful if publicly disclosed
Key Terms – Private Label AgreementGelteq LTD • August 30th, 2022 • Pharmaceutical preparations • Victoria
